"Autologous Hematopoetic Stem Cell Transplantation for Refractory Crohn Disease"
"Conclusions and Relevance Among adult patients with refractory Crohn disease not amenable to surgery who had impaired quality of life, HSCT, compared with conventional therapy, did not result in a statistically significant improvement in sustained disease remission at 1 year and was associated with significant toxicity. These findings do not support the widespread use of HSCT for patients with refractory Crohn disease."
http://jama.jamanetwork.com/article.aspx?articleid=2475462
No comments:
Post a Comment